<DOC>
	<DOCNO>NCT00813475</DOCNO>
	<brief_summary>To test whether tight glucose control associate well clinical outcome compare less-tight control , among diabetic patient hospitalize internal medicine ward .</brief_summary>
	<brief_title>Effect Diabetes Control Outcome Hospitalized Patients : A National Israeli Study</brief_title>
	<detailed_description>Patient characteristic : Patients admit internal medicine department public hospital Israel pre-admission diagnosis diabetes , random plasma glucose &gt; 200 mg/dl admission Eligibility criteria 1 . Age : &gt; 18 year 2 . Fasting plasma glucose &gt; 140 mg/dl non-fasting plasma glucose &gt; 200 mg/dl two separate blood test non-diabetic , single blood test pre-diagnosed diabetes 3 . Able understand study objective method willing provide write informed consent 4 . No significant liver disease 5 . Serum creatinine &lt; 2.0 mg/dl Exclusion criterion 1 . Significant cognitive impairment 2 . History hypoglycemia unawareness clinical autonomic diabetic neuropathy 3 . Known allergy insulin analogues 4 . Diabetic ketoacidosis non-ketotic hyperosmolar coma admission Process patient recruitment randomization : 1 . Enrolment eligible patient sign informed consent . 2 . Assignment patient different treatment arm accord randomization scheme provide central organizing committee . 3 . The ratio patient ' assignment active control study arm 1:1 participate ward . Protocol : Basal bolus insulin treatment apply achieve tight glucose target ( mean fasting blood glucose &lt; 130 mg/dl 180 mg/dl day ) compare patient treat achieve less tight glucose target ( mean fasting blood glucose &lt; 200 mg/dl 220 mg/dl day ) influence cardiovascular general clinical outcome . Primary outcome : All-cause mortality ( include in-hospital 12 month post discharge ) re-admission hospital Secondary outcome : Total number in-hospital day one year follow-up ( include index hospital admission ) The rate major clinical event ( all-cause mortality , hospital acquire infection , organ failure , need ventilation support , need vasoactive amine administration , need central line insertion , hospital admission stroke , acute coronary event , severe bacterial fungal infection ) one year follow-up Hypoglycemic event index hospital stay .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Age : &gt; 18 year 2 . Fasting plasma glucose &gt; 140 mg/dl nonfasting plasma glucose &gt; 200 mg/dl two separate blood test nondiabetic , single blood test prediagnosed diabetes 3 . Able understand study objective method willing provide write informed consent 4 . No significant liver disease 5 . Serum creatinine &lt; 2.0 mg/dl 1 . Significant cognitive impairment 2 . History hypoglycemia unawareness clinical autonomic diabetic neuropathy 3 . Known allergy insulin analogues 4 . Diabetic ketoacidosis nonketotic hyperosmolar coma admission</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>cardio vascular outcome</keyword>
</DOC>